• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Icon accelerates site activation timelines by up to 25%

Icon accelerates site activation timelines by up to 25%

December 9, 2015
CenterWatch Staff

Icon, a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, has accelerated its study startup timelines globally and has achieved a reduction of mean startup cycle times by up to 25%. 

Following a comprehensive review of study startup activities, Icon has adopted a range of new processes and procedures that have streamlined site activation. Unnecessary, time-consuming activities have been eliminated and Icon also has fostered enhanced communication between sites and global teams to improve the predictability and increase the speed in site startup.

Icon has reduced or eliminated many previously manual processes through the implementation of goBalto Activate, which Icon has introduced to all clinical studies in more than 50 countries. The goBalto Activate is a purpose-built software solution that automates study startup by providing country-specific workflows that guide study teams to complete the specific documents and tasks required for activating a site in any country, while tracking progress automatically. Providing status updates and critical path reports in real-time, the solution enhances collaboration between study teams and sites by providing a single area for exchanging documents, recording and updating tasks, monitoring submissions and communicating updates for study startup.

Icon also is using goBalto Analyze for reporting and to provide real-time visibility into startup across multiple studies and regions. Analyze enables Icon to discover meaningful patterns in study startup data and also quantifies study team performance.

“Accelerating study startup is a key component in project delivery optimization and by combining streamlined processes with industry leading tools we are helping our clients take time and cost from their development programs,” said Marie Keegan, vice president and global functional head of study startup at Icon. “With our process improvement initiatives supported by goBalto’s Activate and Analyze solutions, we are able to deliver enhanced study startup results, with median cycle times reduced by up to 25%.”

“The life sciences industry has recognized study startup as one of areas within clinical trials that needs to be significantly enhanced,” said Jae Chung, goBalto’s founder and president. “ICON is taking the lead in automating a cumbersome industry process, with the goal of getting medicines to those in need, faster.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing